✦ LIBER ✦

Pharmacokinetics of bendazac-lysine and 5-hydroxybendazac in patients with renal insufficiency

✍ Scribed by V. Rovei; G. Campistron; J. -M. Dueymes; D. Ego; J. J. Conte; G. Houin

Publisher: Springer
Year: 1987
Tongue: English
Weight: 702 KB
Volume: 33
Category: Article
ISSN: 0031-6970
DOI: 10.1007/bf00637567

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The pharmacokinetics of bendazac-lysine

The pharmacokinetics of bendazac-lysine and 5-hydroxybendazac, its main metabolite, in patients with hepatic cirrhosis

✍ V. Rovei; J. Escourrou; G. Campistron; D. Ego; A. Thiola; A. Ribet; G. Houin 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 533 KB

Pharmacokinetics of ramipril in hyperten

Pharmacokinetics of ramipril in hypertensive patients with renal insufficiency

✍ H. Schunkert; J. Kindler; M. Gassmann; W. Lahn; R. Irmisch; E. Ritz; E. R. Debus 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 958 KB

Cyclophosphamide pharmacokinetics and do

Cyclophosphamide pharmacokinetics and dose requirements in patients with renal insufficiency

✍ Haubitz, Marion; Bohnenstengel, Frank; Brunkhorst, Reinhard; Schwab, Matthias; H 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 219 KB

## Background: Intravenous pulse administration of cyclophosphamide (cyc) has been successfully used for the treatment of various autoimmune diseases. these patients often present with impaired renal function or even end-stage renal failure. nevertheless, data concerning pharmacokinetics of cyc in

Pharmacokinetics of cefadroxil in normal

Pharmacokinetics of cefadroxil in normal subjects and in patients with renal insufficiency

✍ G. Humbert; A. Leroy; J. P. Fillastre; M. Godin 📂 Article 📅 1980 🏛 Springer-Verlag 🌐 English ⚖ 890 KB

Pharmacokinetics and clinical effects of

Pharmacokinetics and clinical effects of cefuroxime in patients with severe renal insufficiency

✍ R. A. Walstad; O. G. Nilsen; K. J. Berg 📂 Article 📅 1983 🏛 Springer 🌐 English ⚖ 722 KB

Pharmacokinetic profile and tolerability

Pharmacokinetic profile and tolerability of pimobendan in patients with terminal renal insufficiency

✍ M. Przechera; W. Roth; V. Kühlkamp; T. Risler; M. Haehl 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 450 KB

The pharmacokinetics of an i.v. bolus of pimobendan (P) 2.5 mg and 5.0 mg, its tolerability and the effect on heart rate and blood pressure have been studied in 12 subjects (42-70 y) suffering from severe terminal renal impairment. Plasma level data were compared with those obtained in a previous in